News‎ > ‎

Achlys Inc.

posted Nov 18, 2016, 2:47 PM by Philip Winter
Achlys is a leading cardiac ion channel company offering better solutions for measuring drug-associated cardiotoxicity. Our expert team from the Universities of Alberta and Calgary offer novel computational and biological assay systems to tell you if your drug candidates inhibit the hERG ion channel or other components within human cardiomyocytes.

Comments